CI
TAK icon

Cowen Inc’s Takeda Pharmaceutical TAK Stock Holding History

Cowen Inc’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-66,000
Closed -$77K – 541
2019
Q1 		$77K Buy
+66,000
New +$1.33M 0.01% 243

Other funds holding TAK

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cowen Inc's TAK Position: Q2 2019 in Review

Cowen Inc increased its Takeda Pharmaceutical (TAK) stake by 1.7% in Q2 2019, buying an estimated $91K and bringing the position to 299,914 shares worth $5.31M. The position accounts for 0.38% of the portfolio, ranked #49.

Cowen Inc first reported a position in TAK in Q4 2018 and has held it in 3 quarters since. The position peaked at $14.4M in Q4 2018. 347 funds tracked by Wall St. Rank hold TAK as of Q2 2019.

  • Cowen Inc held 299,914 shares of Takeda Pharmaceutical worth $5.31M as of Q2 2019.
  • Cowen Inc bought 5,000 Takeda Pharmaceutical shares in Q2 2019, an estimated $91K.
  • Takeda Pharmaceutical made up 0.38% of Cowen Inc's portfolio in Q2 2019, its #49 holding.
  • Cowen Inc first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 3 quarters since.
  • Cowen Inc's Takeda Pharmaceutical position peaked at $14.4M in Q4 2018.
  • 347 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.